We present a fast sequence with high diagnostic accuracy to move towards high-throughput clinical whole-body cancer staging using PET/MRI. Ferumoxytol-contrast enhanced T1-weighted LAVA-Flex is acquired at 16s/bed, at a voxel size of 3.4x1.5x1.9mm. This contrast-enhanced sequence offers superior vessel contrast and resolution to existing T1 co-registration modalities that are most commonly based on MR attenuation correction sequences or longer T1-weighted sequences. Integration of this sequence in a clinical protocol bears the promise of dramatically accelerated whole-body cancer staging with durations <20min, thus offering similar exam times to the more radiation-invasive alternative of PET/CT.
This abstract and the presentation materials are available to members only; a login is required.